Keywords
MetforminMedicineType 2 diabetesTolerabilityPharmacologyDiabetes mellitusType 2 Diabetes MellitusInsulin resistanceBiguanideInsulinInternal medicineClinical trialAdverse effectEndocrinology
Affiliated Institutions
Related Publications
Biguanides and NIDDM
The main biguanides, metformin and phenformin, were introduced in 1957 as oral glucose-lowering agents to treat non-insulin-dependent diabetes mellitus (NIDDM). Phenformin was w...
Metformin
Metformin (dimethylbiguanide) is an orally administered drug used to lower blood glucose concentrations in patients with non-insulin-dependent diabetes mellitus (NIDDM).1 It imp...
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Several lines of evidence have indicated a pathogenic role of insulin resistance, and a st...
U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease
The objective of the U.K. Prospective Diabetes Study is to determine whether improved blood glucose control in type II diabetes will prevent the complications of diabetes and wh...
Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
Metformin is a biguanide that has been shown to effectively lower plasma glucose levels in subjects with noninsulin-dependent diabetes mellitus (NIDDM). However, its mechanism o...
Publication Info
- Year
- 2003
- Type
- review
- Volume
- 25
- Issue
- 12
- Pages
- 2991-3026
- Citations
- 188
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
188
OpenAlex
Cite This
Stephen M. Setter,
Jason L. Iltz,
Jason Thams
et al.
(2003).
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy.
Clinical Therapeutics
, 25
(12)
, 2991-3026.
https://doi.org/10.1016/s0149-2918(03)90089-0
Identifiers
- DOI
- 10.1016/s0149-2918(03)90089-0